Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2012
06/20/2012CN102106912B Medicament for treating white hairs and white beards
06/20/2012CN102091270B Medicament for treating neurodermatitis
06/20/2012CN102078486B Drug composition for removing chloasma and preparation method thereof
06/20/2012CN101965176B Whitening agent and skin external preparation
06/20/2012CN101918014B Medicinal composition
06/20/2012CN101810566B Hydrocortisone butyrate cream
06/20/2012CN101732339B Foot odor preventing medical powder
06/20/2012CN101716277B Method for determining active ingredients of rhizoma smilacis glabrae medicinal material
06/20/2012CN101716203B Pilatory
06/20/2012CN101693038B Pharmaceutical composition for treating skin (A) disease
06/20/2012CN101422556B Exterior-applied medicine for treating dermatopathy
06/20/2012CN101306168B Traditional Chinese medicine taken orally for treating dry seborrheic dermatitis
06/20/2012CN101301462B Decoction for treating cold urticaria
06/19/2012US8202856 Triazole oxadiazoles derivatives
06/19/2012US8202855 Substituted beta-lactams
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2471043C Stable surfactant compositions for suspending components
06/19/2012CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/14/2012WO2012078999A1 Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis
06/14/2012WO2012078574A2 Janus kinase 2 (jak2) inhibitor for the treatment of lupus
06/14/2012WO2012078072A1 Medicinal preparation, method for producing the medicinal preparation and method for the use thereof
06/14/2012WO2012078018A1 Production of standardized extracts of the plant known as "cuachalalate" (amphipterygium adstringens) and uses thereof in the field of sun protection.
06/14/2012WO2012077649A1 Human monoclonal antibody
06/14/2012WO2012077622A1 Therapeutic or prophylactic agent for keloid or hypertrophic scar, and agent for inhibiting tissue hypertrophy in injured part of airway
06/14/2012WO2012076352A1 Composition for topical use for treating skin disorders
06/14/2012WO2012076322A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/14/2012WO2012076321A1 Oligosaccharide composition for treating skin diseases
06/14/2012WO2012075911A1 Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012WO2012050831A3 Combination treatment for dermatological conditions
06/14/2012WO2012032418A3 Activated leukocyte conditioned supernatant and uses for wound healing
06/14/2012WO2012027603A3 Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
06/14/2012US20120150087 Solid dressing for treating wounded tissue
06/14/2012US20120149783 Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
06/14/2012US20120149775 Methods for preventing and improving skin elastic property loss
06/14/2012US20120149773 Composition for skin improvement comprising hexamidines and retinoids
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149748 Pharmaceutical Cream Compositions and Methods of Use
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149731 New medical use
06/14/2012US20120149730 Methods and compositions using racemic, (r)-, and (s)-fexofenadine in combination with leukotriene inhibitors
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149707 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149680 Kinase inhibitors
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149671 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents
06/14/2012US20120149659 Compositions and methods for delivering an agent to a wound
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120148694 Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts
06/14/2012US20120148690 Skin barrier function recovery accelerator
06/14/2012US20120148686 Method of improving skin regeneration effect of medicinal materials by double boiling using earthenware pot
06/14/2012US20120148683 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
06/14/2012US20120148658 Solid dressing for treating wounded tissue
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148633 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148562 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
06/14/2012US20120148541 Compositions and methods to generate pilosebaceous units
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148528 Compositions and methods to induce targeted apoptosis
06/14/2012US20120148526 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012US20120148520 Organic Iodine Complex Durable Barrier With Antimicrobial Preparations
06/14/2012US20120148516 Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
06/14/2012US20120148509 Composition for alleviating ultraviolet irradiation-induced damage
06/14/2012US20120148505 Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
06/14/2012US20120148493 Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2819859A1 Methods for treating baldness and promoting hair growth
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2818941A1 Janus kinase 2 (jak2) inhibitor for the treatment of lupus
06/14/2012CA2818011A1 Oligosaccharide composition for treating skin diseases
06/14/2012CA2817122A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/13/2012EP2462121A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
06/13/2012EP2461806A2 Antiangiogenic small molecules and methods of use
06/13/2012EP1824775B1 Debriding composition from bromelain and methods of production thereof
06/13/2012EP1789053B1 Method of wound healing using a2b adenosine receptor antagonists
06/13/2012EP1776119B9 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497873A Compositions and methods for increasing lifespan and health span
06/13/2012CN102497868A Mixture of non-digestible oligosaccharides for stimulating the immune system
06/13/2012CN102497851A Injectable composition combining a filling agent and a fibroblast growth medium
06/13/2012CN102491963A Compound I and II, their application and preparation method in preparing medicines for preventing formation of melanins
06/13/2012CN102488880A Human body massage liquid prepared from ginger essential oil, preparation method thereof, and massage liquid supplying apparatus
06/13/2012CN102488878A External traditional Chinese medicine composition for treating leucoderma
06/13/2012CN102488873A Chinese medicinal preparation for treating urticaria
06/13/2012CN102488870A Compound propolis composition for treating pruritus for dogs and cats and preparation method thereof
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1065